{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:04:36Z","timestamp":1790438676648,"version":"4.1.0"},"reference-count":37,"publisher":"BMJ","issue":"6","funder":[{"name":"Equity Trustee\u2019s"},{"DOI":"10.13039\/501100022099","name":"Cerebral Palsy Alliance","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022099","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,5,15]]},"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Fetal growth restriction (FGR) is a serious pregnancy complication, associated with increased rates of perinatal death and morbidity among survivors. Most commonly FGR results from placental insufficiency, where the placenta fails to deliver the oxygen and nutrients required for normal fetal growth. This leads to fetal oxidative stress, resulting in organ damage through lipid peroxidation. The early developing brain is particularly susceptible, such that FGR is associated with poorer neurodevelopment, witnessed as cognitive and behavioural dysfunction, and cerebral palsy. Promisingly, melatonin, a lipid soluble antioxidant is neuroprotective in animal models of FGR. We present a protocol outlining a randomised, placebo-controlled trial to explore whether antenatal maternal melatonin supplementation in pregnancies with severe, early-onset FGR can improve neurodevelopment among survivors at 2 years of age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analyses<\/jats:title>\n                    <jats:p>We will recruit 336 women with a singleton pregnancy complicated by FGR between 23+0\u2009and 31+6 weeks gestation. Participants will be randomised, stratified by gestational age, to either 30\u2009mg melatonin per day or a visually identical placebo, continued until birth. Measures of maternal and fetal health will be collected until birth. Timing of birth will be determined by the treating clinical team in discussion with the woman. Neonatal and infant neurodevelopmental assessments will be undertaken, consisting of brain MRI at term corrected age, general movements assessment at term and 3 months\u2019 corrected age, and Bayley Scales of Infant &amp; Toddler Development-III and Infant Toddler Social Emotional Assessment at 2.5 years corrected age. Analyses will be on intention to treat. The primary outcome is a difference of 5 points in the cognitive domain of the Bayley-III. Secondary outcomes address maternal and fetal safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This trial has Monash Health Human Research and Ethics committee approval (17-0000-583A). Findings will be disseminated through peer-reviewed publications, conference presentations and to participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ACTRN12617001515381; Pre-results<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-028243","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T13:39:19Z","timestamp":1561210759000},"page":"e028243","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7421-6291","authenticated-orcid":false,"given":"Kirsten R","family":"Palmer","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia"},{"name":"Department of Obstetrics and Gynaecology, Monash Health, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne C","family":"Mockler","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia"},{"name":"Department of Obstetrics and Gynaecology, Monash Health, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1918-5538","authenticated-orcid":false,"given":"Miranda L","family":"Davies-Tuck","sequence":"additional","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-8304","authenticated-orcid":false,"given":"Suzanne L","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia"},{"name":"The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy K","family":"Goergen","sequence":"additional","affiliation":[{"name":"Department of Imaging, Monash University, Clayton, Victoria, Australia"},{"name":"Department of Radiology, Monash Health, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0811-4785","authenticated-orcid":false,"given":"Michael C","family":"Fahey","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Monash Health, Clayton, Victoria, Australia"},{"name":"Department of Paediatrics, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7430-868X","authenticated-orcid":false,"given":"Peter J","family":"Anderson","sequence":"additional","affiliation":[{"name":"Monash Institute of Cognitive and Clinical Neuroscience, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5495-5617","authenticated-orcid":false,"given":"Katie M","family":"Groom","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Liggins Institute, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4506-5233","authenticated-orcid":false,"given":"Euan M","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia"},{"name":"The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,6,22]]},"reference":[{"issue":"Suppl 1","key":"2025121411412884000_9.6.e028243.1","first-page":"S5","article-title":"Levels and patterns of intrauterine growth retardation in developing countries","volume":"52","author":"de Onis","year":"1998","journal-title":"Eur J Clin Nutr"},{"key":"2025121411412884000_9.6.e028243.2","doi-asserted-by":"publisher","DOI":"10.1159\/000357592"},{"key":"2025121411412884000_9.6.e028243.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f108"},{"key":"2025121411412884000_9.6.e028243.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.08.055"},{"key":"2025121411412884000_9.6.e028243.5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-1143"},{"key":"2025121411412884000_9.6.e028243.6","doi-asserted-by":"crossref","first-page":"S869","DOI":"10.1016\/j.ajog.2017.12.012","article-title":"Long-term cardiovascular consequences of fetal growth restriction: biology, clinical implications, and\u00a0opportunities for prevention of adult disease","volume":"218","author":"Crispi","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"2025121411412884000_9.6.e028243.7","doi-asserted-by":"crossref","first-page":"130.e1","DOI":"10.1016\/j.ajog.2012.11.014","article-title":"Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction","volume":"208","author":"von Beckerath","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"2025121411412884000_9.6.e028243.8","doi-asserted-by":"publisher","DOI":"10.1159\/000353631"},{"key":"2025121411412884000_9.6.e028243.9","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2008.01.001"},{"key":"2025121411412884000_9.6.e028243.10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1470320316654810","article-title":"Increased renal apoptosis and reduced renin-angiotensin system in fetal growth restriction","volume":"17","author":"Wang","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2025121411412884000_9.6.e028243.11","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0000000000000051"},{"key":"2025121411412884000_9.6.e028243.12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1017\/S2040174417000265","article-title":"Endothelial dysfunction in individuals born after fetal growth restriction: cardiovascular and renal consequences and preventive approaches","volume":"8","author":"Yzydorczyk","year":"2017","journal-title":"J Dev Orig Health Dis"},{"key":"2025121411412884000_9.6.e028243.13","doi-asserted-by":"publisher","DOI":"10.1113\/JP271402"},{"key":"2025121411412884000_9.6.e028243.14","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1016\/j.ajog.2017.11.565","article-title":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction","volume":"218","author":"Groom","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"2025121411412884000_9.6.e028243.15","doi-asserted-by":"publisher","DOI":"10.1002\/uog.19186"},{"key":"2025121411412884000_9.6.e028243.16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2025121411412884000_9.6.e028243.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1998.tb00550.x"},{"key":"2025121411412884000_9.6.e028243.18","doi-asserted-by":"publisher","DOI":"10.1007\/BF02253360"},{"key":"2025121411412884000_9.6.e028243.19","doi-asserted-by":"crossref","first-page":"e12514","DOI":"10.1111\/jpi.12514","article-title":"Melatonin and its metabolites vs oxidative stress: From individual actions to collective protection","volume":"65","author":"Galano","year":"2018","journal-title":"J Pineal Res"},{"key":"2025121411412884000_9.6.e028243.20","doi-asserted-by":"crossref","first-page":"e12508","DOI":"10.1111\/jpi.12508","article-title":"Melatonin improves endothelial function in vitro and prolongs pregnancy in women with early-onset preeclampsia","volume":"65","author":"Hobson","year":"2018","journal-title":"J Pineal Res"},{"key":"2025121411412884000_9.6.e028243.21","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12121"},{"key":"2025121411412884000_9.6.e028243.22","doi-asserted-by":"publisher","DOI":"10.1002\/uog.6286"},{"key":"2025121411412884000_9.6.e028243.23","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13435"},{"key":"2025121411412884000_9.6.e028243.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586"},{"key":"2025121411412884000_9.6.e028243.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2000.tb03338.x"},{"key":"2025121411412884000_9.6.e028243.26","doi-asserted-by":"publisher","DOI":"10.1002\/uog.5315"},{"key":"2025121411412884000_9.6.e028243.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.09.019"},{"key":"2025121411412884000_9.6.e028243.28","doi-asserted-by":"crossref","unstructured":"Einspieler C , Prechtl HFR , Ferrari F , et al . The qualitative assessment of general movements in preterm, term and young infants - Review of the methodology. Vol. 50, Early Human Development: Elsevier, 1997:47\u201360.","DOI":"10.1016\/S0378-3782(97)00092-3"},{"key":"2025121411412884000_9.6.e028243.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2006.03.005"},{"key":"2025121411412884000_9.6.e028243.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2011.01.032"},{"key":"2025121411412884000_9.6.e028243.31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.945"},{"key":"2025121411412884000_9.6.e028243.32","doi-asserted-by":"publisher","DOI":"10.1002\/uog.13190"},{"key":"2025121411412884000_9.6.e028243.33","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/1471-0528.14555","article-title":"Gestational age at diagnosis of early-onset fetal growth restriction and impact on management and survival: a population-based cohort study","volume":"124","author":"Monier","year":"2017","journal-title":"BJOG"},{"key":"2025121411412884000_9.6.e028243.34","doi-asserted-by":"publisher","DOI":"10.1159\/000333001"},{"key":"2025121411412884000_9.6.e028243.35","first-page":"513","article-title":"GRIT study group. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial","volume":"364","author":"Thornton","year":"2005","journal-title":"Lancet"},{"key":"2025121411412884000_9.6.e028243.36","unstructured":"Universities Australia, National Health and Medical Research Council,\u00a0Australian Research Council. Australian Code for the Responsible Conduct of Research: Australian Government, 2007:1\u201334."},{"key":"2025121411412884000_9.6.e028243.37","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2011.636094"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-028243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T19:41:36Z","timestamp":1765741296000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-028243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,22]]},"published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1136\/bmjopen-2018-028243"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-028243","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}